Market Tracker

07/22 9:10am ET

Celgene Corp (NASDAQ:CELG)

85.31
Data as of Jul 21
 +0.25 / +0.29%
Today’s Change
65.76
Today|||52-Week Range
90.50
+0.98%
Year-to-Date

Today’s Trading

Previous close85.06
Today’s open84.81
Day’s range-- - --
Volume2,925,496
Average volume (3 months)5,136,421
Market cap$68.1B
Dividend yield--
Data as of 07/21/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.12%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+19.49%
P/E ratio54.3
Price/Sales10.78
Price/Book12.51

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.17+0.27%
ABTAbbott Laboratories+0.23+0.54%
ACTActavis PLC-2.05-0.94%
BMYBristol-Myers Squibb...-0.20-0.41%
Data as of 07/21/2014

Financials

Next reporting dateJuly 24, 2014
EPS forecast (this quarter)$0.89
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
Chief Operating Officer &
Executive Vice President
Perry A. Karsen
Corporate headquarters
Summit, New Jersey

Forecasts